Barbara Eichhorst
About
In The Last Decade
Barbara Eichhorst
179 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Genetics 6.8k
- Pathology and Forensic Medicine 5.3k
- Immunology 2.8k
- Hematology 1.8k
- Oncology 1.3k
Countries citing papers authored by Barbara Eichhorst
This map shows the geographic impact of Barbara Eichhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Eichhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Eichhorst more than expected).
Fields of papers citing papers by Barbara Eichhorst
This network shows the impact of papers produced by Barbara Eichhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Eichhorst. The network helps show where Barbara Eichhorst may publish in the future.
Co-authorship network of co-authors of Barbara Eichhorst
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Eichhorst. A scholar is included among the top collaborators of Barbara Eichhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Eichhorst. Barbara Eichhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 8 | |
| 7 | 0 | |
| 8 | 17 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy | 1 |
| 12 | 8 | |
| 13 | 5 | |
| 14 | 7 | |
| 15 | 35 | |
| 16 | 133 | |
| 17 | 238 | |
| 18 | 13 | |
| 19 | 201 | |
| 20 | Fludarabine induces higher response rates in first line therapy of older patients with advanced chronic lymphocytic leukemia than chlorambucil Interim analysis of a phase III study of the German CLL Study Group | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.